Application of medication therapy management-based “in-hospital assessment - home-based intervention” pharmaceutical care in patients with depression

Table 2 Longitudinal comparison of medication adherence between two groups of patients with depression

Indicator	Time point	Intervention group (n = 52)	Control group (n = 52)	χ2/t value	P value
MPR ≥ 80%	Baseline	18 (34.62)	19 (36.54)	0.042	0.838
	3 months	30 (57.69)	21 (40.38)	7.093	0.008
	6 months	37 (71.15)	22 (42.31)	9.415	0.002
	9 months	40 (76.92)	24 (46.15)	11.236	0.001
Dose omission rate (times/person/month)	3 months	0.45 ± 0.25	1.20 ± 0.50	9.246	< 0.001
	6 months	0.32 ± 0.18	1.05 ± 0.41	11.832	< 0.001
	9 months	0.28 ± 0.15	0.95 ± 0.38	10.573	< 0.001
Self-reduction rate (times/person/month)	3 months	0.25 ± 0.15	0.80 ± 0.35	9.872	< 0.001
	6 months	0.15 ± 0.11	0.68 ± 0.33	10.647	< 0.001
	9 months	0.12 ± 0.09	0.60 ± 0.30	9.328	< 0.001

Data are presented as mean ± SD or n (%).

MPR: Medication possession rate.